$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Key Physicochemical and Biological Factors of the Phase Behavior of Tau 원문보기

Chem, v.6 no.11, 2020년, pp.2924 - 2963  

Nam, Geewoo ,  Lin, Yuxi ,  Lim, Mi Hee ,  Lee, Young-Ho

초록이 없습니다.

참고문헌 (155)

  1. Proc. Natl. Acad. Sci. USA Weingarten 72 1858 1975 10.1073/pnas.72.5.1858 A protein factor essential for microtubule assembly 

  2. ACS Chem. Biol. Savelieff 8 856 2013 10.1021/cb400080f Untangling amyloid-β, tau, and metals in Alzheimer’s disease 

  3. Chem. Rev. Savelieff 119 1221 2019 10.1021/acs.chemrev.8b00138 Development of multifunctional molecules as potential therapeutic candidates for Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis in the last decade 

  4. Nature Rauch 580 381 2020 10.1038/s41586-020-2156-5 LRP1 is a master regulator of tau uptake and spread 

  5. Brain Gratuze 139 1014 2016 10.1093/brain/aww021 Is Huntington's disease a tauopathy? 

  6. Brain Res. Brain Res. Rev. Buée 33 95 2000 10.1016/S0165-0173(00)00019-9 Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 

  7. Cold Spring Harb. Perspect. Med. Mandelkow 2 a006247 2012 10.1101/cshperspect.a006247 Biochemistry and cell biology of Tau protein in neurofibrillary degeneration 

  8. Nat. Rev. Neurosci. Ballatore 8 663 2007 10.1038/nrn2194 Tau-mediated neurodegeneration in Alzheimer's disease and related disorders 

  9. Physiol. Rev. Avila 84 361 2004 10.1152/physrev.00024.2003 Role of Tau protein in both physiological and pathological conditions 

  10. Lancet Neurol. Spillantini 12 609 2013 10.1016/S1474-4422(13)70090-5 Tau pathology and neurodegeneration 

  11. Science Goedert 314 777 2006 10.1126/science.1132814 A century of Alzheimer's disease 

  12. Brain Pathol. McKee 25 350 2015 10.1111/bpa.12248 The neuropathology of chronic traumatic encephalopathy 

  13. Neuron Morris 70 410 2011 10.1016/j.neuron.2011.04.009 The many faces of tau 

  14. J. Neurol. Choudhury 267 2697 2020 10.1007/s00415-020-09927-9 Pick’s disease: clinicopathologic characterization of 21 cases 

  15. Nature Zhang 580 283 2020 10.1038/s41586-020-2043-0 Novel tau filament fold in corticobasal degeneration 

  16. Lancet Neurol. Williams 8 270 2009 10.1016/S1474-4422(09)70042-0 Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges 

  17. Curr. Neurol. Neurosci. Rep. Armstrong 18 12 2018 10.1007/s11910-018-0819-5 Progressive supranuclear palsy: an update 

  18. Acta Neuropathol. Crary 128 755 2014 10.1007/s00401-014-1349-0 Primary age-related tauopathy (PART): a common pathology associated with human aging 

  19. J. Mol. Biol. Cleveland 116 227 1977 10.1016/0022-2836(77)90214-5 Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly 

  20. Chembiochem Smet 5 1639 2004 10.1002/cbic.200400145 Accepting its random coil nature allows a partial NMR assignment of the neuronal Tau protein 

  21. Protein Pept. Lett. Lippens 13 235 2006 10.2174/092986606775338461 Studying the natively unfolded neuronal tau protein by solution NMR spectroscopy 

  22. PLoS Biol. Mukrasch 7 e1000034 2009 10.1371/journal.pbio.1000034 Structural polymorphism of 441-residue tau at single residue resolution 

  23. Biophys. J. Zhao 112 921 2017 10.1016/j.bpj.2017.01.024 Glycan determinants of heparin-tau interaction 

  24. Biochemistry Jeganathan 47 10526 2008 10.1021/bi800783d The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments 

  25. Biochemistry Jeganathan 45 2283 2006 10.1021/bi0521543 Global hairpin folding of tau in solution 

  26. Nature Fitzpatrick 547 185 2017 10.1038/nature23002 Cryo-EM structures of tau filaments from Alzheimer’s disease 

  27. ACS Chem. Biol. Despres 14 1363 2019 10.1021/acschembio.9b00325 Major differences between the self-assembly and seeding behavior of heparin-induced and in vitro phosphorylated tau and their modulation by potential inhibitors 

  28. Am. J. Pathol. Arrasate 151 1115 1997 Role of glycosaminoglycans in determining the helicity of paired helical filaments 

  29. Nat. Commun. Levin 5 5219 2014 10.1038/ncomms6219 Ostwald’s rule of stages governs structural transitions and morphology of dipeptide supramolecular polymers 

  30. ACS Nano Lin 13 8766 2019 10.1021/acsnano.9b01578 Diverse structural conversion and aggregation pathways of Alzheimerʼs amyloid-β (1-40) 

  31. Nature Goedert 383 550 1996 10.1038/383550a0 Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans 

  32. Mol. Neurodegener. Lasagna-Reeves 6 39 2011 10.1186/1750-1326-6-39 Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice 

  33. Sci. Rep. Lasagna-Reeves 2 700 2012 10.1038/srep00700 Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau 

  34. J. Alzheimers Dis. Castillo-Carranza 40 S97 2014 10.3233/JAD-132477 Specific targeting of tau oligomers in htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds 

  35. Neurosci. Res. Maeda 54 197 2006 10.1016/j.neures.2005.11.009 Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease 

  36. Biochemistry Maeda 46 3856 2007 10.1021/bi061359o Granular tau oligomers as intermediates of tau filaments 

  37. Front. Mol. Biosci. Kontaxi 4 56 2017 10.3389/fmolb.2017.00056 Lysine-directed post-translational modifications of tau protein in Alzheimer's disease and related tauopathies 

  38. Front. Neurol. Noble 4 83 2013 10.3389/fneur.2013.00083 The importance of tau phosphorylation for neurodegenerative diseases 

  39. Mol. Neurodegener. Nübling 7 35 2012 10.1186/1750-1326-7-35 Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level 

  40. Proc. Natl. Acad. Sci. USA Despres 114 9080 2017 10.1073/pnas.1708448114 Identification of the tau phosphorylation pattern that drives its aggregation 

  41. Acta Neuropathol. Commun. Ercan-Herbst 7 192 2019 10.1186/s40478-019-0823-2 A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain 

  42. J. Neurochem. Andorfer 86 582 2003 10.1046/j.1471-4159.2003.01879.x Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms 

  43. Proc. Natl. Acad. Sci. USA Alonso 98 6923 2001 10.1073/pnas.121119298 Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments 

  44. Nat. Commun. Cohen 2 252 2011 10.1038/ncomms1255 The acetylation of tau inhibits its function and promotes pathological tau aggregation 

  45. Nat. Med. Min 21 1154 2015 10.1038/nm.3951 Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits 

  46. Sci. Rep. Trzeciakiewicz 7 44102 2017 10.1038/srep44102 A dual pathogenic mechanism links tau acetylation to sporadic tauopathy 

  47. Alzheimers Res. Ther. Cook 6 29 2014 10.1186/alzrt259 Acetylation: a new key to unlock tau’s role in neurodegeneration 

  48. Sci. Adv. Frenkel-Pinter 3 e1601576 2017 10.1126/sciadv.1601576 Interplay between protein glycosylation pathways in Alzheimer’s disease 

  49. Nat. Med. Wang 2 871 1996 10.1038/nm0896-871 Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease 

  50. FEBS Lett. Liu 530 209 2002 10.1016/S0014-5793(02)03487-7 Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3β 

  51. FEBS Lett. Liu 512 101 2002 10.1016/S0014-5793(02)02228-7 Role of glycosylation in hyperphosphorylation of tau in Alzheimer’s disease 

  52. Sci. Rep. Losev 9 2254 2019 10.1038/s41598-019-39218-x Novel model of secreted human Tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity 

  53. Proc. Natl. Acad. Sci. USA Liu 101 10804 2004 10.1073/pnas.0400348101 O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease 

  54. J. Mol. Biol. Yuzwa 426 1736 2014 10.1016/j.jmb.2014.01.004 O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers 

  55. Proc. Natl. Acad. Sci. USA Goedert 85 4051 1988 10.1073/pnas.85.11.4051 Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau 

  56. Cell. Mol. Life Sci. Fontaine 72 1863 2015 10.1007/s00018-015-1839-9 Cellular factors modulating the mechanism of Tau protein aggregation 

  57. Biochemistry Li 45 15692 2006 10.1021/bi061422+ Characterization of two VQIXXK motifs for tau fibrillization in vitro 

  58. J. Biol. Chem. von Bergen 276 48165 2001 10.1074/jbc.M105196200 Mutations of Tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure 

  59. Proc. Natl. Acad. Sci. USA von Bergen 97 5129 2000 10.1073/pnas.97.10.5129 Assembly of Tau protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure 

  60. Nature Falcon 561 137 2018 10.1038/s41586-018-0454-y Structures of filaments from Pick’s disease reveal a novel Tau protein fold 

  61. Nature Falcon 568 420 2019 10.1038/s41586-019-1026-5 Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules 

  62. eLife Zhang 8 e43584 2019 10.7554/eLife.43584 Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases 

  63. Cell Arakhamia 180 633 2020 10.1016/j.cell.2020.01.027 Posttranslational modifications mediate the structural diversity of tauopathy strains 

  64. J. Biol. Chem. Lippens 294 9316 2019 10.1074/jbc.REV119.008031 Elucidating tau function and dysfunction in the era of cryo-EM 

  65. Science Shin 357 eaaf4382 2017 10.1126/science.aaf4382 Liquid phase condensation in cell physiology and disease 

  66. J. Biol. Chem. Mukrasch 280 24978 2005 10.1074/jbc.M501565200 Sites of tau important for aggregation populate β-structure and bind to microtubules and polyanions 

  67. J. Biol. Chem. Hasegawa 272 33118 1997 10.1074/jbc.272.52.33118 Alzheimer-like changes in microtubule-associated protein tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the depend on the degree of sulfation 

  68. J. Biol. Chem. Zhu 285 3592 2010 10.1074/jbc.M109.035691 Quantitative characterization of heparin binding to Tau protein: implication for inducer-mediated tau filament formation 

  69. Chem. Commun. Fichou 54 4573 2018 10.1039/C8CC01355A Heparin-induced tau filaments are structurally heterogeneous and differ from Alzheimer’s disease filaments 

  70. Biochemistry Sibille 45 12560 2006 10.1021/bi060964o Structural impact of heparin binding to full-length tau as studied by NMR spectroscopy 

  71. Biochemistry Pérez 40 5983 2001 10.1021/bi002961w In vitro assembly of Tau protein: mapping the regions involved in filament formation 

  72. ACS Chem. Neurosci. Kjaergaard 9 3060 2018 10.1021/acschemneuro.8b00250 Oligomer diversity during the aggregation of the repeat region of tau 

  73. Biochem. Biophys. Res. Commun. Bader 411 190 2011 10.1016/j.bbrc.2011.06.135 Single particle analysis of tau oligomer formation induced by metal ions and organic solvents 

  74. Am. J. Pathol. Stieber 148 415 1996 In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic 

  75. Biochim. Biophys. Acta Iqbal 1739 198 2005 10.1016/j.bbadis.2004.09.008 Tau pathology in Alzheimer disease and other tauopathies 

  76. Angew. Chem. Int. Ed. Zhao 59 1818 2020 10.1002/anie.201913029 3-O-sulfation of heparan sulfate enhances tau interaction and cellular uptake 

  77. Biochemistry Morozova 52 6960 2013 10.1021/bi400866w Conformational features of tau fibrils from Alzheimer’s disease brain are faithfully propagated by unmodified recombinant protein 

  78. Proc. Natl. Acad. Sci. USA Holmes 110 E3138 2013 10.1073/pnas.1301440110 Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds 

  79. PLoS One Huynh 14 e0209573 2019 10.1371/journal.pone.0209573 Glycosaminoglycans from Alzheimer’s disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau 

  80. Ann. Neurol. Ginsberg 41 200 1997 10.1002/ana.410410211 Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques 

  81. FEBS Lett. Kampers 399 344 1996 10.1016/S0014-5793(96)01386-5 RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments 

  82. Biochemistry Dinkel 54 4731 2015 10.1021/acs.biochem.5b00453 RNA binds to tau fibrils and sustains template-assisted growth 

  83. Proc. Natl. Acad. Sci. USA Fichou 115 13234 2018 10.1073/pnas.1810058115 Cofactors are essential constituents of stable and seeding-active tau fibrils 

  84. Chem. Rev. Kepp 112 5193 2012 10.1021/cr300009x Bioinorganic chemistry of Alzheimer’s disease 

  85. Biochemistry Soragni 47 10841 2008 10.1021/bi8008856 Structural characterization of binding of Cu(II) to Tau protein 

  86. Biopolymers Ma 79 74 2005 10.1002/bip.20335 Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR 

  87. Anal. Biochem. Martic 442 130 2013 10.1016/j.ab.2013.07.015 Probing copper/tau protein interactions electrochemically 

  88. Peptides Zhou 28 2229 2007 10.1016/j.peptides.2007.08.022 Copper (II) modulates in vitro aggregation of a tau peptide 

  89. Peptides Ma 27 841 2006 10.1016/j.peptides.2005.09.002 Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS 

  90. Inorg. Chem. Du 53 11221 2014 10.1021/ic501788v Inhibitory act of selenoprotein P on Cu+/Cu2+-induced tau aggregation and neurotoxicity 

  91. ACS Omega Ahmadi 4 5356 2019 10.1021/acsomega.8b03595 Aggregation of microtubule binding repeats of tau protein is promoted by Cu2+ 

  92. J. Biol. Chem. Mo 284 34648 2009 10.1074/jbc.M109.058883 Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322 

  93. Biochim. Biophys. Acta Mol. Basis Dis. Hu 1863 414 2017 10.1016/j.bbadis.2016.11.022 Pathological concentration of zinc dramatically accelerates abnormal aggregation of full-length human tau and thereby significantly increases tau toxicity in neuronal cells 

  94. Chemistry Jiji 23 16976 2017 10.1002/chem.201704555 Zn2+ interrupts R4-R3 association leading to accelerated aggregation of tau protein 

  95. Int. J. Mol. Sci. Li 20 487 2019 10.3390/ijms20030487 Zn2+ aggravates tau aggregation and neurotoxicity 

  96. Cell Rep. Huang 8 831 2014 10.1016/j.celrep.2014.06.047 Zinc binding directly regulates tau toxicity independent of tau hyperphosphorylation 

  97. Electrochim. Acta Ahmadi 236 384 2017 10.1016/j.electacta.2017.03.175 Electrochemical studies of tau protein-iron interactions-potential implications for Alzheimer’s disease 

  98. J. Neurochem. Yamamoto 82 1137 2002 10.1046/j.1471-4159.2002.t01-1-01061.x Iron (III) induces aggregation of hyperphosphorylated τ and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease 

  99. Science Perl 208 297 1980 10.1126/science.7367858 Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons 

  100. Neurochem. Res. Li 23 1467 1998 10.1007/BF03181171 Phosphorylation sensitizes microtubule-associated protein τ to Al3+-induced aggregation 

  101. J. Biol. Chem. Chirita 278 25644 2003 10.1074/jbc.M301663200 Anionic micelles and vesicles induce tau fibrillization in vitro 

  102. Biophys. J. Elbaum-Garfinkle 98 2722 2010 10.1016/j.bpj.2010.03.013 The role of the lipid bilayer in tau aggregation 

  103. Acta Neuropathol. Mena 91 633 1996 10.1007/s004010050477 Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer’s disease 

  104. Chem. Phys. Lipids Schroeder 92 1 1998 10.1016/S0009-3084(98)00003-6 Fatty acid binding protein isoforms: structure and function 

  105. Biophys. J. Georgieva 107 1441 2014 10.1016/j.bpj.2014.07.046 Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats 

  106. J. Mol. Biol. Barré 362 312 2006 10.1016/j.jmb.2006.07.018 Folding of the repeat domain of tau upon binding to lipid surfaces 

  107. Protein Sci. Barré 22 1037 2013 10.1002/pro.2290 Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule-binding repeats in filament nucleation 

  108. Nano Lett. Mari 18 3271 2018 10.1021/acs.nanolett.8b01085 Reversible cation-selective attachment and self-assembly of human tau on supported brain lipid membranes 

  109. Nat. Commun. Ait-Bouziad 8 1678 2017 10.1038/s41467-017-01575-4 Discovery and characterization of stable and toxic tau/phospholipid oligomeric complexes 

  110. Biochemistry Konno 43 13613 2004 10.1021/bi048549o Anionic contribution for fibrous maturation of protofibrillar assemblies of the human tau repeat domain in a fluoroalcohol solution 

  111. Biochim. Biophys. Acta Proteins Proteom. Jebarupa 1866 668 2018 10.1016/j.bbapap.2018.04.004 Effect of altered solution conditions on tau conformational dynamics: plausible implication on order propensity and aggregation 

  112. J. Pept. Sci. Chaudhary 15 675 2009 10.1002/psc.1172 Morphology of self-assembled structures formed by short peptides from the amyloidogenic protein tau depends on the solvent in which the peptides are dissolved 

  113. Biophys. Chem. Jebarupa 241 27 2018 10.1016/j.bpc.2018.07.005 Conformational heterogeneity of tau: implication on intrinsic disorder, acid stability and fibrillation in Alzheimer's disease 

  114. Protein Sci. Cheon 21 1514 2012 10.1002/pro.2141 Influence of temperature on formation of perfect tau fragment fibrils using PRIME20/DMD simulations 

  115. Int. J. Mol. Sci. Kuznetsova 15 23090 2014 10.3390/ijms151223090 What macromolecular crowding can do to a protein 

  116. Int. J. Mol. Sci. Ma 14 21339 2013 10.3390/ijms141121339 The role of crowded physiological environments in prion and prion-like protein aggregation 

  117. J. Biol. Chem. Zhou 284 30148 2009 10.1074/jbc.M109.002832 Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding 

  118. Int. J. Biol. Macromol. Wu 90 27 2016 10.1016/j.ijbiomac.2015.11.091 Effects of macromolecular crowding and osmolyte on human tau fibrillation 

  119. Int. J. Mol. Sci. Macchi 13 3801 2012 10.3390/ijms13033801 The effect of osmolytes on protein fibrillation 

  120. Biochem. Biophys. Res. Commun. Tseng 250 726 1998 10.1006/bbrc.1998.9382 Natural methylamine osmolytes, trimethylamine N-oxide and betaine, increase tau-induced polymerization of microtubules 

  121. Biochemistry Scaramozzino 45 3684 2006 10.1021/bi052167g TMAO promotes fibrillization and microtubule assembly activity in the C-terminal repeat region of tau 

  122. Proc. Natl. Acad. Sci. USA Levine 112 2758 2015 10.1073/pnas.1418155112 Regulation and aggregation of intrinsically disordered peptides 

  123. J. Phys. Chem. B Eschmann 119 14421 2015 10.1021/acs.jpcb.5b08092 Tau aggregation propensity engrained in its solution state 

  124. Annu. Rev. Biochem. Kim 82 323 2013 10.1146/annurev-biochem-060208-092442 Molecular chaperone functions in protein folding and proteostasis 

  125. Cell Stress Chaperones Radons 21 379 2016 10.1007/s12192-016-0676-6 The human HSP70 family of chaperones: where do we stand? 

  126. Ann. N. Y. Acad. Sci. Johnson 695 194 1993 10.1111/j.1749-6632.1993.tb23051.x Heat-shocked neuronal PC12 cells reveal Alzheimer's disease-associated alterations in amyloid precursor protein and Tau 

  127. Hum. Mol. Genet. Petrucelli 13 703 2004 10.1093/hmg/ddh083 CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation 

  128. Cell Chem. Biol. Young 23 992 2016 10.1016/j.chembiol.2016.04.014 Stabilizing the Hsp70-Tau complex promotes turnover in models of tauopathy 

  129. Biochemistry Voss 51 888 2012 10.1021/bi2018078 Hsp70 alters tau function and aggregation in an isoform specific manner 

  130. Biochemistry Patterson 50 10300 2011 10.1021/bi2009147 Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport 

  131. ACS Chem. Biol. Kundel 13 636 2018 10.1021/acschembio.7b01039 Hsp70 inhibits the nucleation and elongation of tau and sequesters tau aggregates with high affinity 

  132. Mol. BioSyst. Sarkar 4 895 2008 10.1039/b804606a Small molecule enhancers of autophagy for neurodegenerative diseases 

  133. Proc. Natl. Acad. Sci. USA Dou 100 721 2003 10.1073/pnas.242720499 Chaperones increase association of tau protein with microtubules 

  134. J. Clin. Invest. Dickey 117 648 2007 10.1172/JCI29715 The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins 

  135. Cell Karagöz 156 963 2014 10.1016/j.cell.2014.01.037 Hsp90-Tau complex reveals molecular basis for specificity in chaperone action 

  136. J. Clin. Invest. Blair 123 4158 2013 10.1172/JCI69003 Accelerated neurodegeneration through chaperone-mediated oligomerization of tau 

  137. Nat. Commun. Oroz 9 4532 2018 10.1038/s41467-018-06880-0 Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex 

  138. Mol. Cell. Neurosci. Bulbarelli 42 75 2009 10.1016/j.mcn.2009.06.001 Pin1 affects tau phosphorylation in response to Aβ oligomers 

  139. Proc. Natl. Acad. Sci. USA Shelton 114 9707 2017 10.1073/pnas.1707039114 Hsp90 activator Aha1 drives production of pathological tau aggregates 

  140. J. Neurosci. Res. Björkdahl 86 1343 2008 10.1002/jnr.21589 Small heat shock proteins Hsp27 or αB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments 

  141. J. Neurosci. Abisambra 30 15374 2010 10.1523/JNEUROSCI.3155-10.2010 Phosphorylation dynamics regulate Hsp27-mediated rescue of neuronal plasticity deficits in tau transgenic mice 

  142. J. Biol. Chem. Baughman 293 2687 2018 10.1074/jbc.M117.803411 HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation 

  143. Nat. Commun. Freilich 9 4563 2018 10.1038/s41467-018-07012-4 Competing protein-protein interactions regulate binding of Hsp27 to its client protein tau 

  144. J. Biol. Chem. Liu 293 14880 2018 10.1074/jbc.RA118.004034 Mechanistic insights into the switch of αB-crystallin chaperone activity and self-multimerization 

  145. Front. Cell Dev. Biol. Perri 3 80 2016 10.3389/fcell.2015.00080 The unfolded protein response and the role of protein disulfide isomerase in neurodegeneration 

  146. PLoS One Xu 8 e76657 2013 10.1371/journal.pone.0076657 Protein disulfide isomerase interacts with Tau protein and inhibits its fibrillization 

  147. Science Brangwynne 324 1729 2009 10.1126/science.1172046 Germline P granules are liquid droplets that localize by controlled dissolution/condensation 

  148. Nat. Commun. Ambadipudi 8 275 2017 10.1038/s41467-017-00480-0 Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau 

  149. PLoS Biol. Zhang 15 e2002183 2017 10.1371/journal.pbio.2002183 RNA stores tau reversibly in complex coacervates 

  150. eLife Lin 8 e42571 2019 10.7554/eLife.42571 Narrow equilibrium window for complex coacervation of tau and RNA under cellular conditions 

  151. EMBO J. Wegmann 37 e98049 2018 10.15252/embj.201798049 Tau protein liquid-liquid phase separation can initiate tau aggregation 

  152. Cell Rep. Hernández-Vega 20 2304 2017 10.1016/j.celrep.2017.08.042 Local nucleation of microtubule bundles through tubulin concentration into a condensed tau phase 

  153. Proc. Natl. Acad. Sci. USA Ikenoue 111 6654 2014 10.1073/pnas.1322602111 Heat of supersaturation-limited amyloid burst directly monitored by isothermal titration calorimetry 

  154. Langmuir Lin 30 1845 2014 10.1021/la403100h Solubility and supersaturation-dependent protein misfolding revealed by ultrasonication 

  155. Cell Alberti 176 419 2019 10.1016/j.cell.2018.12.035 Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로